Please contact us with any other questions.
John G. Figueroa first became one of our directors in November 2012 when he joined us as Chairman of our board of directors and also served in the dual roles as Chief Executive Officer of the Company and of our home infusion therapy segment from November of 2012 until January 2014. Since September 2019, Mr. Figueroa has served as the Chairman and Chief Executive Officer of CarepathRX, a company providing innovative pharmacy solutions to hospital health systems. He also served as Chief Executive Officer of Genoa Healthcare, the leading behavioral health specialty pharmacy in the United States from 2014 to 2018. Prior to his appointment to these roles, Mr. Figueroa served as Chief Executive Officer and board member of Cincinnati, Ohio-based Omnicare, Inc., a Fortune 500 healthcare services company that provides pharmaceuticals and related services to long-term care facilities and specialized drugs for complex disease states. Before that, Mr. Figueroa served as President of McKesson Corporation’s U.S. Pharmaceutical Group from 2006 to 2010, after holding progressively more responsible operations and sales positions in the company’s Supply Solutions, Pharmaceutical and Health Systems groups from 1997 through early 2006. He spent the initial years of his career in various sales and operations roles for Baxter Healthcare Corporation’s Hospitex and Medical Surgical divisions. He served as an Officer in the US Army as a Ranger and with Special Forces. Figueroa currently serves as a director and the Chairman of the Compensation Committee and member of the Governance Committee of Reliance Steel & Aluminum Co., and on the Executive Committee for the board at Pepperdine University Graziadio School of Business. Mr. Figueroa holds B.A.s in English Literature and Political Science from the University of California at Los Angeles and received his M.B.A. from Pepperdine University in California.
Michael Audet became one of our directors in June 2019. Mr. Audet is a Managing Director at Blackstone in Strategic Partners. Since initially joining Blackstone in 2010, Mr. Audet previously worked in Blackstone’s private equity business where he was involved in the execution of Blackstone’s investments in Paysafe, First Eagle Asset Management, Tradesmen International, Summit Materials, and Apria Healthcare. Mr. Audet received an AB in mathematics from Dartmouth College, where he graduated summa cum laude and was elected to Phi Beta Kappa, and a Masters of Business Administration with Distinction from Harvard Business School. He is also a Co-Chair of the New Wave Steering Committee for Film at Lincoln Center.
John R. Murphy became one of our directors in August 2019. Mr. Murphy currently serves on the Board of Directors of O’Reilly Automotive, Inc., Alight Solutions LLC and Summit Materials, Inc. Previously, he served on the Board of Directors of DJO Global, Inc., Graham Packaging, Inc. and Accuride Corporation, Inc. He previously served as Interim Chief Financial Officer of Summit Materials, Inc. in 2013, Senior Vice President and Chief Financial Officer of Smurfit-Stone Container Corporation from 2009 to 2010, and Chief Financial Officer, then President and Chief Operating Officer, then President and Chief Executive Officer with Accuride Corporation, Inc. from 1998 to 2008. Mr. Murphy holds a Bachelor of Science in Accounting from Pennsylvania State University and a Master of Business Administration from the University of Colorado, and is a Certified Public Accountant.
Norman C. Payson, M.D. first became one of our directors in 2006 and served as our Executive Chairman of the Board of Directors and Chief Executive Officer from October 2008 until November 2012 when he retired as Executive Chairman and as Chief Executive Officer and became a Senior Advisor to us while remaining a member of our Board of Directors. He was Chief Executive Officer of Oxford Health Plans from 1998 through 2002. Dr. Payson co-founded Healthsource, Inc., a large health plan operating in 15 states, in 1985 and served as its Chief Executive Officer from 1985 through 1997. He currently serves as Chairman of the board of directors of Access Clinical Partners, an integrated urgent care health network operating in ten states. He is also Chairman Emeritus of the board of directors of City of Hope, a not-for-profit tertiary cancer hospital and research center. Dr. Payson previously served as a member of the board of directors of Evolent Health Holdings Inc. (NYSE: EVH) from December 2013 to June 2019 and as a consultant of Evolent Health Holdings Inc. from March 2014 through December 2020. He is also a board member of Progyny, a fertility benefits provider and also serves as a Director of Smile Brands, one of the nation’s leading Dental Support Organizations with over 350 locations across 15 states. Dr. Payson is an Emeritus Board Member of Geisel School of Medicine at Dartmouth, as well as a member of the Mailman School of Public Health at Columbia HPM National Advisory Board, and a member of the USC Schaeffer Center Advisory Board. Dr. Payson holds a B.S. from the Massachusetts Institute of Technology in Cambridge, Massachusetts and received his medical degree from Dartmouth Medical School in New Hampshire.
Devon Rinker is a nominee to our board of directors and a Principal in Blackstone’s Private Equity Group. Since joining Blackstone in 2017, Mr. Rinker has been involved with Blackstone’s investments in HealthMarkets, NCR, SERVPRO, and Exeter Finance. He previously served as a director on the board of directors of HealthMarkets. Before joining Blackstone, Mr. Rinker was an Associate at KKR, where he evaluated and executed private equity investments in the technology, media, and communications industries. Prior to that, he worked in investment banking at Evercore Partners. Mr. Rinker received a B.S. in Commerce from the University of Virginia, where he graduated with distinction and Beta Gamma Sigma, and an M.B.A. from Harvard Business School.
Neil P. Simpkins became one of our directors immediately after the completion of our acquisition by private investment funds affiliated with our Sponsor in October 2008. He is a Senior Managing Director of Blackstone’s Corporate Private Equity Group. Since joining Blackstone in 1998, Mr. Simpkins has led the acquisitions of TRW Automotive, Vanguard Health Systems, TeamHealth, Gates Industrial Corporation plc, Change Healthcare and Summit Materials. Before joining Blackstone, Mr. Simpkins was a Principal at Bain Capital. While at Bain Capital, Mr. Simpkins was involved in the execution of investments in the consumer products, industrial, healthcare and information industries. Prior to joining Bain Capital, Mr. Simpkins was a consultant at Bain & Company in the Asia Pacific region and in London. He currently serves as a director of Change Healthcare Inc., Gates Industrial Corporation plc, and TeamHealth Holdings, Inc.
Lynn Shapiro Snyder became one of our directors in August 2019. Ms. Snyder currently is a senior Member of Epstein Becker Green (“EBG”) in the Health Care and Life Sciences and Litigation practices in the firm’s Washington, DC office, and she is a Strategic Counsel with EBG Advisors, Inc. and National Health Advisors. Ms. Snyder has over 40 years of experience at EBG, advising a wide variety of clients about federal, state, and international health law/policy/commercial issues, including Medicare, Medicaid, TRICARE, VA, managed care, compliance, privacy, security, artificial intelligence, FDA, coding, coverage and payment issues. Ms. Snyder is also Founder and President of the Women Business Leaders of the U.S. Health Care Industry Foundation (“The WBL Foundation”). Ms. Snyder currently is a board member of the following companies: The Trustmark Mutual Holding Company on the Audit and Compensation Committees, EBG as the Vice Chair of Finance Committee; and The WBL Foundation as the Chairperson of the Board. She is a graduate of Franklin & Marshall College and George Washington University National Law Center.
Daniel J. Starck has served as our Chief Executive Officer since February 2015. Prior to assuming this role, Mr. Starck served as the Chief Executive Officer of our home respiratory therapy and home medical equipment segment since he joined the Company in April 2012 and became one of our Directors in December 2013. Prior to joining us, from 2006 to 2012, Mr. Starck served as Chief Executive Officer of CorVel Corporation (“CorVel”), an Orange County, California-based national provider of industry-leading workers’ compensation solutions for employers, third-party administrators, insurance companies, and government agencies seeking to control costs and promote positive outcomes. Mr. Starck joined CorVel in 2006 as President and Chief Operating Officer after serving Apria and a predecessor company in a series of progressively more responsible operations roles from 1992 to 2006. Mr. Starck holds a B.S. in Business from San Diego State University in California.
Mike S. Zafirovski became one of our directors in October 2011. Mr. Zafirovski is the founder and president of The Zaf Group LLC, which he established in November 2012. Since October 2011, Mr. Zafirovski has served as an Executive Advisor to The Blackstone Group Inc. and serves on the boards of certain Blackstone portfolio companies. Previously, he served as director, President and Chief Executive Officer of Nortel Networks Corporation from November 2005 to August 2009. Prior to that, Mr. Zafirovski was director, President and Chief Operating Officer of Motorola, Inc. (“Motorola”) from July 2002 to January 2005, and remained a consultant to and a director of Motorola until May 2005. He served as Executive Vice President and President of the Personal Communications Sector (mobile devices) of Motorola from June 2000 to July 2002. Prior to joining Motorola, Mr. Zafirovski spent nearly 25 years with General Electric Company, where he served in management positions, including 13 years as President and Chief Executive Officer of five businesses in the industrial and financial services arenas, his most recent being President and Chief Executive Officer of GE Lighting from July 1999 to May 2000. Mr. Zafirovski also serves on the board of Stericycle, Inc. and served on the board of the Boeing Company for 16 years until retiring in May 2020. Mr. Zafirovski holds a B.A. in Mathematics from Edinboro University in Pennsylvania.
Terri Kline served as the Executive Vice President of Henry Ford Health System (HFHS) a health care provider, and the President and Chief Executive Officer of Health Alliance Plan, a health insurance company and subsidiary of HFHS from November 2016 through June 2019. From July 2014 to November 2016, Ms. Kline provided healthcare consulting services. Ms. Kline served as Senior Vice President and Chief Health Care Management Officer of Health Care Service Corporation (a health insurance company) from March 2010 to March 2014. Since November 2019, Ms. Kline has served as a member of the board of directors of Amedisys, a home health and hospice company. Since August 2017, Ms. Kline has served as a member of the board of directors of Intersect ENT, a medical device and specialty pharmaceutical company. Since August 2017, Ms. Kline has served on the board of directors of SaVida Health, an opioid use disorder treatment company. Since October 2015, Ms. Kline has also served as a member of the board of directors of Presbyterian Health Plan, Inc. (a health insurer) and as Vice Chairman since January 2017. Ms. Kline holds a B.A. from Kalamazoo College and an M.P.H. from the University of Michigan.
Susannah Gray was the Executive Vice President and Chief Financial Officer of Royalty Pharma (the largest aggregator of pharmaceutical royalty interests worldwide) from January 2005 through November 2018, at which point she took on the additional responsibility of heading Strategy for the company. Prior to joining Royalty Pharma, Ms. Gray had a 14-year career in banking, working in various capacities within high-yield and structured finance departments of Chase Securities, Merrill Lynch, and CIBC World Markets. In addition to the Apria board, Ms. Gray currently serves on the board of directors of 4D Molecular Therapeutics, where she serves on the Audit Committee and chairs the Compensation Committee, Maravai Life Sciences where she chairs the Audit Committee, and Morphic Therapeutics, where she sits on the Audit Committee. She is also a board member of the private company, BioSplice Therapeutics. Ms. Gray sits the board of a number of nonprofit organizations, including Wesleyan University, the Susan G. Komen Foundation, Street Squash, and the German Marshall Fund. Ms. Gray earned a B.A. with honors from Wesleyan University and an M.B.A. from Columbia University.